Skip to main content

Table 2 Stability test of pilocarpine solution filled in a Hybripack® tube

From: New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life

Time (day)

Pilocarpine concentration (μg/mL) a

Residual (%)

0

0.56 ± 0.03

100

3

0.52 ± 0.02

92.8

7

0.59 ± 0.01

105.3

14

0.55 ± 0.02

98.4

28

0.55 ± 0.01

98.6

  1. a: Data are expressed as means ± SD (n = 3)